Literature DB >> 12403228

Effect of red blood cell glucose-6-phosphate dehydrogenase deficiency on patients with dengue hemorrhagic fever.

Voravarn S Tanphaichitr1, Rachaneekorn Chonlasin, Lerlugsn Suwantol, Parichat Pung-Amritt, Kalaya Tachavanich, Suthee Yogsan, Vip Viprakasit.   

Abstract

Eighty nine males aged 1-13 years diagnosed with dengue haemorrhagic fever (DHF) and admitted to the Department of Pediatrics Siriraj Hospital from March 1998 to April 2000 were included in this study. 17 cases (19.1%) had red blood cell glucose-6-phosphate dehydrogenase (G-6-PD) deficiency and 72 cases (80.9%) had normal G-6-PD enzyme activities. Most of the patients were classified as DHF grade II in severity. 3 of 17 G-6-PD deficient cases had serious complications and all of them had acute intravascular hemolysis requiring blood transfusions. One of these also had hematemesis, one had azothemia and the other one had renal failure and severe liver failure with hepatic encephalopathy. In the cases without obvious hemolytic or hepatic complications, G-6-PD deficient cases had mildly but significantly higher total birirubin and indirect bilirubin, as well as a lower hematocrit than those who had normal G-6-PD. Reticulocyte count was low during the acute phase, however, during recovery, the levels were significantly increased in both groups. In the non G-6-PD deficient group, G-6-PD enzyme levels were significantly decreased during the acute phase compared to the normal controls but rose significantly to normal levels during the recovery phase. There were no statistically significant differences in other laboratory data. All patients recovered fully from DHF. The prevalence of G-6-PD deficiency in male patients who had DHF in this study was 19.1 per cent which was higher than the prevalence in a previous study of 12 per cent in Bangkok. This may imply that G-6-PD deficient males suffer more from DHF compared to normal G-6-PD subjects.

Entities:  

Mesh:

Year:  2002        PMID: 12403228

Source DB:  PubMed          Journal:  J Med Assoc Thai        ISSN: 0125-2208


  5 in total

1.  Atypical dengue Fever in a splenectomized boy with glucose-6- phosphodehydrogenase deficiency and thalassemia intermedia.

Authors:  Veronique Dinand; Vera Metzler; Satya Prakash Yadav; Anupam Sachdeva
Journal:  Indian J Pediatr       Date:  2010-12-17       Impact factor: 1.967

2.  Systematic review of the clinical manifestations of glucose-6-phosphate dehydrogenase deficiency in the Greater Mekong Subregion: implications for malaria elimination and beyond.

Authors:  Ken Ing Cherng Ong; Hodaka Kosugi; Sophea Thoeun; Hitomi Araki; Moe Moe Thandar; Moritoshi Iwagami; Bouasy Hongvanthong; Paul T Brey; Shigeyuki Kano; Masamine Jimba
Journal:  BMJ Glob Health       Date:  2017-08-19

3.  Higher infection of dengue virus serotype 2 in human monocytes of patients with G6PD deficiency.

Authors:  Yuan-Chang Chao; Ching-Shan Huang; Chun-Nan Lee; Sui-Yuan Chang; Chwan-Chuen King; Chuan-Liang Kao
Journal:  PLoS One       Date:  2008-02-13       Impact factor: 3.240

4.  Dengue virus type 2 (DENV2)-induced oxidative responses in monocytes from glucose-6-phosphate dehydrogenase (G6PD)-deficient and G6PD normal subjects.

Authors:  Abdullah Ahmed Al-Alimi; Syed A Ali; Faisal Muti Al-Hassan; Fauziah Mohd Idris; Sin-Yeang Teow; Narazah Mohd Yusoff
Journal:  PLoS Negl Trop Dis       Date:  2014-03-13

5.  Impact of glucose-6-phosphate dehydrogenase deficiency on dengue infection in Myanmar children.

Authors:  Win Lai May; Myat Phone Kyaw; Stuart D Blacksell; Sasithon Pukrittayakamee; Kesinee Chotivanich; Borimas Hanboonkunupakarn; Khin Nyo Thein; Chae Seung Lim; Janjira Thaipadungpanit; Thomas Althaus; Podjanee Jittamala
Journal:  PLoS One       Date:  2019-01-02       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.